Search for Topics:
Title/Keyword
Journal
Submission Status
Category
 
 
Topics
Research in Pharmacological Therapies, 2nd Edition
Submit your Manuscript Submit your Abstract Propose a Topic

Topic Menu

► Topic Menu

Topic Editors

Freshage Research Group, Department of Physiology, Faculty of Medicine, University of Valencia, E46010 Valencia, Spain
Department of Physiology, Faculty of Pharmacy, University of Valencia, Vicente Andrés Estellés Av. s/n, 46100 Burjassot, Spain
share announcement

Research in Pharmacological Therapies, 2nd Edition

Abstract submission deadline
30 October 2025
Manuscript submission deadline
30 December 2025
Viewed by
2622

Topic Information

Dear Colleagues,

Drugs are bioactive compounds that are present in chemical structures in both the plant and animal kingdoms. Both organic and inorganic compounds have been used empirically to cure diseases or to treat the symptoms that are derived from them. Much of modern pharmacology has its origins in these types of compounds. Due to advancements in chemistry, we are able to characterize the chemical composition of any compound with a high degree of accuracy. In fact, to this day, we are continuing to discover new compounds in nature that demonstrate very promising pharmacological activities, which could lay the foundation for new, more efficient, and more effective bioactive molecules through chemical modifications. Furthermore, pharmacology is advancing as new synthetic compounds with increasingly specific and effective pharmacological properties are being developed at a rapid pace. Therefore, as a part of this topic, we plan to collect the latest advances in new drugs of either natural or synthetic origin in addition to describing their biological targets, their specific mechanisms of action, and their effective dosages.

Dr. Juan Gambini
Dr. Ángel Luis Ortega
Topic Editors

Keywords

  • pharmacological therapies
  • drugs
  • bioactive compounds
  • pharmacological activities
  • natural or synthetic origin
  • biological targets

Participating Journals

Journal Name Impact Factor CiteScore Launched Year First Decision (median) APC
Biomedicines
biomedicines 		3.9 5.2 2013 14.6 Days CHF 2600 Submit
International Journal of Molecular Sciences
ijms 		4.9 8.1 2000 16.8 Days CHF 2900 Submit
Medicines
medicines 		- - 2014 28.6 Days CHF 1400 Submit
Pharmaceuticals
pharmaceuticals 		4.3 6.1 2004 13.9 Days CHF 2900 Submit
Scientia Pharmaceutica
scipharm 		2.3 4.6 1930 26.1 Days CHF 1000 Submit

Preprints.org is a multidisciplinary platform offering a preprint service designed to facilitate the early sharing of your research. It supports and empowers your research journey from the very beginning.

MDPI Topics is collaborating with Preprints.org and has established a direct connection between MDPI journals and the platform. Authors are encouraged to take advantage of this opportunity by posting their preprints at Preprints.org prior to publication:

  1. Share your research immediately: disseminate your ideas prior to publication and establish priority for your work.
  2. Safeguard your intellectual contribution: Protect your ideas with a time-stamped preprint that serves as proof of your research timeline.
  3. Boost visibility and impact: Increase the reach and influence of your research by making it accessible to a global audience.
  4. Gain early feedback: Receive valuable input and insights from peers before submitting to a journal.
  5. Ensure broad indexing: Web of Science (Preprint Citation Index), Google Scholar, Crossref, SHARE, PrePubMed, Scilit and Europe PMC.

Published Papers (1 paper)

Order results
Result details
Journals
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
32 pages, 1496 KiB  
Review
Osteoporosis: Causes, Mechanisms, Treatment and Prevention: Role of Dietary Compounds
by Kristine Stromsnes, Cristian Martinez Fajardo, Silvana Soto-Rodriguez, Erika Ria Ulrika Kajander, Remus-Iulian Lupu, Monica Pozo-Rodriguez, Balma Boira-Nacher, Maria Font-Alberich, Marcos Gambini-Castell, Gloria Olaso-Gonzalez, Maria-Carmen Gomez-Cabrera and Juan Gambini
Pharmaceuticals 2024, 17(12), 1697; https://doi.org/10.3390/ph17121697 - 16 Dec 2024
Cited by 2 | Viewed by 2221
Abstract
Osteoporosis is a chronic disease that is characterized by a loss of bone density, which mainly affects the microstructure of the bones due to a decrease in bone mass, thereby making them more fragile and susceptible to fractures. Osteoporosis is currently considered one [...] Read more.
Osteoporosis is a chronic disease that is characterized by a loss of bone density, which mainly affects the microstructure of the bones due to a decrease in bone mass, thereby making them more fragile and susceptible to fractures. Osteoporosis is currently considered one of the pandemics of the 21st century, affecting around 200 million people. Its most serious consequence is an increased risk of bone fractures, thus making osteoporosis a major cause of disability and even premature death in the elderly. In this review, we discuss its causes, the biochemical mechanisms of bone regeneration, risk factors, pharmacological treatments, prevention and the effects of diet, focusing in this case on compounds present in a diet that could have palliative and preventive effects and could be used as concomitant treatments to drugs, which are and should always be the first option. It should be noted as a concluding remark that non-pharmacological treatments such as diet and exercise have, or should have, a relevant role in supporting pharmacology, which is the recommended prescription today, but we cannot ignore that they can have a great relevance in the treatment of this disease. Full article
(This article belongs to the Topic Research in Pharmacological Therapies, 2nd Edition)
►▼ Show Figures

Figure 1

Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
 
Displaying articles 1-1
Back to TopTop